Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Trial of Structured Treatment Interruption(STI) Followed by Initiation of a New Antiretroviral Regimen(ARV) Versus Immediate Switching to a New ARV in HIV-Infected Patients Experiencing Virologic Failure on HAART

NCT00188851 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00188851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00188851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Trial of Structured Treatment Interruption(STI) Followed by Initiation of a New Antiretroviral Regimen(ARV) Versus Immediate Switching to a New ARV in HIV-Infected Patients Experiencing Virologic Failure on HAART
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2001
Completion date
November 30, 2005
Enrollment
196
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv